Tumor Microenvironment in Pancreato-biliary Cancers: Crosstalk, Complexity, and Therapeutic Opportunities
Journal of Bio-X Research · 01.01.2026 · 9
DOI: 10.34133/jbioxresearch.0082 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Bio-X Research, online erschienen am 18.06.2026. Verfasst von Parthiban Ramanathan und 6 weiteren Autor:innen. Die Arbeit nennt 67 Literaturangaben.
Abstract (Originalsprache)
Pancreato-biliary cancers, including pancreatic ductal adenocarcinoma, cholangiocarcinoma, and gallbladder cancer, develop through complex interactions within the tumor microenvironment. These tumors exhibit a dense stroma, immune suppression, and metabolic alterations that support growth and resistance to therapy. Crosstalk between cancer cells and stromal elements such as cancer-associated fibroblasts, tumor-associated macrophages, and myeloid-derived suppressor cells promotes progression through the transforming growth factor-β, interleukin-6/STAT3 (signal transducer and activator of transcription 3), CXCL12 (C-X-C motif chemokine ligand 12)/CXCR4, and Hedgehog pathways. Mutations in KRAS (Kirsten rat sarcoma viral oncogene homolog), TP53, and SMAD4 enhance these processes by enabling epithelial–mesenchymal transition, immune escape, and abnormal angiogenesis. Advances in single-cell and spatial transcriptomics, proteogenomics, and metabolomics have revealed immune and stromal patterns that are correlated with clinical outcomes and treatment response. These discoveries demonstrate that the tumor microenvironment actively drives disease progression. Current therapeutic efforts aim to modify the stroma, improve the vascular structure, reduce hypoxia, and combine immune checkpoint inhibitors with targeted or metabolic treatments. Nanotechnology-based delivery systems and organoid coculture platforms support precision approaches that reflect the spatial and functional features of the tumor microenvironment. A clearer understanding of these interactions is essential for overcoming resistance and improving patient outcomes through combined and individualized treatment strategies.
Zitieren
APA
Ramanathan, P., Ekambaram, B., Gujjula, T. R., Vijayan, M. R., Nandakumar, K., Murugathirumal, A., & Valliappan, S. (2026). Tumor Microenvironment in Pancreato-biliary Cancers: Crosstalk, Complexity, and Therapeutic Opportunities. Journal of Bio-X Research, 9. https://doi.org/10.34133/jbioxresearch.0082
Vancouver
Ramanathan P, Ekambaram B, Gujjula TR, Vijayan MR, Nandakumar K, Murugathirumal A, et al. Tumor Microenvironment in Pancreato-biliary Cancers: Crosstalk, Complexity, and Therapeutic Opportunities. Journal of Bio-X Research. 2026;9. doi:10.34133/jbioxresearch.0082
BibTeX
@article{Ramanathan2026,
author = {Ramanathan, Parthiban and Ekambaram, Bhavya and Gujjula, Teja Reddy and Vijayan, Mohan Raj and Nandakumar, Krishnapriya and Murugathirumal, Akshaya and Valliappan, Sanjay},
title = {Tumor Microenvironment in Pancreato-biliary Cancers: Crosstalk, Complexity, and Therapeutic Opportunities},
journal = {Journal of Bio-X Research},
year = {2026},
volume = {9},
doi = {10.34133/jbioxresearch.0082}
}
EUVIMED